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It has been previously reported that N-terminus of mutant huntingtin (product of the
1st exon) is sufficient to cause a Huntington’s disease (HD) pathological phenotype.
In view of recent data suggesting that improper regulation of store-operated calcium
(SOC) channels is involved in neurodegenerative processes, we investigated influence
of expression of the mutant huntingtin N-terminal fragment (Htt138Q-1exon) on SOC
entry (SOCE) in mouse neuroblastoma cells (Neuro-2a) and in primary culture of
medium spiny neurons (MSNs) isolated from mice. The results show that SOCE in
these cells is enhanced upon lentiviral expression of the Htt138Q-1exon. Moreover,
we demonstrated that RNAi-mediated knockdown of TRPC1, Orai1, or STIM1 proteins
leads to dramatic reduction of abnormal SOCE in both Neuro-2a and MSNs, expressing
Htt138Q-1exon. Thus, we concluded that abnormal SOCE in these cells is maintained
by both TRPC1- and Orai1-containing channels and required STIM1 for its activation.
Furthermore, EVP4593 compound previously tested as a potential anti-HD drug in a
Drosophila screening system has proved to be capable of reducing SOCE to the normal
level in MSNs expressing the Htt138Q-1exon.
Keywords: store-operated calcium entry, Huntington’s disease, ionic channels, neurodegeneration, TRPC1, Orai1,
STIM1
INTRODUCTION
Huntington’s disease (HD) is a hereditary neurodegenerative disorder caused by the expansion of
CAG repeat in the gene encoding huntingtin, a protein of unknown function, with the consequent
expansion of polyglutamine tract in this gene product. In addition to HD, eight more inherited
neurodegenerative diseases are known to be caused by polyglutamine expansion in the protein
products of other genes, which form insoluble aggregates in neurons. It has been reported that
some forms of huntingtin aggregation contribute to neuronal death (Bates, 2003; Arribat et al.,
2013). Furthermore, the results of recent research indicate that many neurodegenerative disorders
are associated with abnormal neuronal calcium signaling (Wojda et al., 2008; Bezprozvanny, 2009;
Melachroinou et al., 2013; Abeti and Abramov, 2015; Leal and Gomes, 2015).
Store-operated calcium entry (SOCE) is well known to be an important and ubiquitous
mechanism for calcium influx in mammalian cells. The activity of SOC channels has
been demonstrated both in nonexcitable cells (Parekh and Penner, 1997) and in neurons
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(Bouron et al., 2005). The SOCE pathway is activated
in response to stimulation of plasma membrane receptors
coupled with phospholipase C. It catalyzes the hydrolysis of
phosphatidylinositol 4,5-bisphosphate to produce inositol 1,4,5-
trisphosphate (IP3), and subsequent activation of the receptor
for IP3 results in depletion of intracellular calcium stores, which
results in calcium influx through the SOC channels.
The molecular players mediating SOCE include STIM1
(stromal interaction molecule 1), a transmembrane protein that
can function as a calcium sensor in the endoplasmic ER lumen.
Upon calcium store depletion, STIM1 is enriched and forms
clusters in close proximity to the plasma membrane, where it
interacts with and activates the SOC channels (Liou et al., 2005;
Dziadek and Johnstone, 2007).
The search for pore-forming proteins mediating SOCE has
resulted in identification of two protein families: Orai and
transient receptor potential canonical (TRPC) proteins. The
Orai1 protein forms highly selective calcium-permeable channels
named calcium-released activated calcium (CRAC) channels.
Despite the large number of investigations indicated that
members of the TRPC family appear to contribute to SOCE,
the data on some TRPCs are as yet equivocal. Evidence for
the involvement in SOCE is more conclusive in case of the
TRPC1 protein, suggesting that it is an integral component of
SOC channels in human submandibular gland cells (Liu et al.,
2000, 2003). It has also been reported that siRNA knockdown of
TRPC1 in differentiated H19-7 hippocampal precursor cells leads
to a dramatic drop in the level of thapsigargin-stimulated SOCE
(Piron and Villereal, 2013). The results of our previous studies
show that TRPC1-composed Imax channels are very important
for SOCE in HEK293 cells (Skopin et al., 2013). It has been
also found that TRPC1 may represent a potential drug target
for treating neurodegeneration and glutamate toxicity (Wu et al.,
2011; Narayanan et al., 2014). Here we investigated the role
of TRPC1 in SOCE pathway in neuronal cells expressing the
product of the mutant huntigtin exon 1 (Htt138Q-1exon).
Striatal medium spiny neurons (MSNs) are most strongly
affected in HD pathology. Therefore, investigation of influence
of mutated huntingtin on MSN’s phenotype can be considered
highly representative.
We have previously described abnormal calcium homeostasis
in human neuroblastoma cells (SK-N-SH) transfected with
full-length mutated huntingtin (Glushankova et al., 2010; Wu
et al., 2011). Here we demonstrate that SOCE is pathologically
enhanced in MSNs and mouse neuroblastoma cells (Neuro-
2a) expressing Htt138Q-1exon. We also present evidence that
TRPC1 and Orai1 are involved in the maintenance of SOCE
in these cells and that the endoplasmic calcium sensor STIM1




Mouse neuroblastoma Neuro-2a cells from the collection of
the Institute of Cytology, Russian Academy of Sciences, were
cultured in DMEM (Biolot, Russia) with 5% fetal bovine serum
(Gibco, United States) and 80 g/mL gentamicin (Biolot, Russia).
One or two days before the experiments, the cells were plated
onto coverslips (3×3mm) coated with polylysine (Sigma, United
States) for better adhesion.
The primary culture of MSNs was established from newborn
mice (C3HA, postnatal day 1) as previously described (Tang et al.,
2005). Briefly, striata were dissected, diced, and digested with
trypsin. After dissociation, neurons were plated on polylysine
coated coverslips and cultured in Neurobasal A medium with 3%
fetal bovine serum and 3% B-27 supplement (Gibco).
All animal experiments were in accordance with the guidelines
for the welfare of animals of the ethical committee of the Institute
of Cytology, Russian Academy of Sciences.
Lentiviral Infection
Viruses Lenti-Htt138Q-1exon, Lenti-Htt15Q-1exon, Lenti-
antiSTIM1, Lenti-antiOrai1, and Lenti-antiTRPC1 were
produced by cotransfection of shuttle vectors encoding
HA-tagged huntingtin gene exon 1 or shRNA with vector
plasmids HIV-1 8.9 (18.9) and VSVG (Sigma) that encoded
glycoproteins required for packaging the vectors in the
HEK293T (human embryonic kidney) cell line. Virus titer
measurements and immunostaining were performed using
primary mouse antibodies to the HA tag (Sigma) and secondary
Cy3 fluorophore-conjugated rabbit antibodies to mouse IgG
(Jackson Immunoresearch, United States). Cell cultures were
infected on day 2 (Neuro-2a) or day 5 (MSNs) using viral titers
(in range from 1:5 to 1:3) with a high level of transfection
efficiency (no less than 90%).
Protein Electrophoresis and Western
Blotting
Cells were grown in 50-mm Petri dishes. After transfection, they
were lysed in 10mMTris-HCl buffer, pH 7.5, with 150mMNaCl,
1% Triton X-100, 1% NP40 (Nonidet P40, nonionic detergent
nonylphenoxypolyethoxylethanol), 2mM EDTA, 0.2mM PMSF
(serine protease inhibitor, phenylmethanesulfonylfluoride), and
protease inhibitor cocktail (Hoffmann–La Roche AG, Germany).
Proteins were resolved by electrophoresis in 8% polyacrylamide
gel and transferred onto nitrocellulose membrane, which
was treated with primary polyclonal anti-TRPC1 antibodies
(Alomone Labs, Israel) diluted 1: 200 (or anti-Orai1 antibodies
(Sigma) diluted 1: 1000) and secondary peroxidase-conjugated
goat antibodies to rabbit IgG (Sigma) diluted 1: 30,000. For
STIM1 detection nitrocellulose membrane was treated with
primary monoclonal anti-STIM1 antibodies (BD Bioscience,
United States) diluted 1: 250 and secondary peroxidase-
conjugated goat antibodies to mouse IgG heavy chain constant
region (Sigma) diluted 1: 30,000. Target proteins were visualized
using the Super Signal Chemiluminiscent Substrate (Pierce,
United States). All experiments were performed in at least three
replications with different cell lysates. Monoclonal anti-α-tubulin
antibodies (Sigma) diluted 1: 1000 were used for loading control.
Relative protein contents were estimated using standard software
for comparing the intensity of bands in scanned blots.
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Ca2+ Imaging
Neuro-2a cells grown on glass coverslips were loaded with
5µM Fura-2AM (Invitrogen, United States) in the presence of
0.025% Pluronic (Invitrogen) for 40min at room temperature.
Loaded cells were illuminated by alternating 340- and 380-nm
excitation light at 2Hz. The emission fluorescence intensity was
measured at 510 nm with an InCyt Basic I/P dual wavelength
fluorescence imaging system (Intracellular Imaging Inc., United
States). Changes in cytosolic Ca2+ concentration were evaluated
by calculating the ratio of emission fluorescence intensities at 340
and 380 nm excitation wavelengths (the 340/380 ratio).
Electrophysiological Experiments
Ion currents were recorded using the whole-cell patch-clamp
technique (Hamill and Sakmann, 1981). The measurements were
made with an Axopatch 200B amplifier (Axon Instruments,
United States). The microelectrode resistance was 5–10 MOm;
the series resistance was not compensated. Series resistance
values were in range of 10–25 MOm and controlled all along
the experiment. The signal enhanced and filtered by an internal
2-pole Bessel filter (section frequency 5000Hz) was digitized at
5000Hz using an AD convertor plate (L-Card, Russia). During
the recording of integral currents, the membrane potential was
held at −40mV. Membrane potential was periodically (every
5 s) dropped to −80mV (for 30ms), then gradually (1mV/ms)
increased to 60mV and then returned to−40mV.Measurements
were made at 0.5-mV intervals. The recorded currents were
normalized relative to cell capacitance (10–30 pF). The traces
recorded prior to current activation were used as templates for
leak subtraction.
In experiments with knockdown of TRPC1, STIM1, or
Orai1, Neuro-2a cells or MSNs were infected with lentiviral
particles containing shRNAs against TRPC1 (NM_011643),
STIM1 (NM_009287), or Orai1 (NM_175423) (Sigma), with the
untargeted shRNA construct SHC002 (Sigma) used as a control.
The efficiency of knockdown was confirmed by Western blotting
for TRPC1 (Figures 3C, 5D), STIM1 (Figures 2B, 5C), and Orai1
(Figures 3D, 5E).
The solution in the pipette for whole-cell current
measurements was as follows: 125mM CsCl2, 10mM EGTA-
Cs, 30mM HEPES-Cs, 4.5mM CaCl2, 1.5mM MgCl2, 4mM
Na-ATP (pCa 7, pH 7.3). The extracellular solution contained
140mM NMDG-Asp, 10mM BaCl2, 30mM HEPES-Cs, and
0.01mM nifedipine (pH 7.3); for activation of store-operated
currents, 1µM thapsigargin (Sigma) was added. The solution in
the chamber was changed within less than 1 s.
Statistics
The data represent the mean ± standard error of the mean
Statistical comparisons were made using One-Way ANOVAwith
Bonferroni correction. The results were considered statistically
significant at p < 0.05.
Chemicals and Drugs
Most chemicals used in the study were from Sigma,
including NaCl, KCl, CsCl2, CaCl2, MgCl2, BaCl2, NaHCO3,
K2HPO4, NaH2PO4, Na-ATP, glucose, aspartic acid,
FIGURE 1 | Effect of the lentiviral expression of Htt138Q-1exon on the
level of store-operated calcium currents in Neuro-2a cells. (A)
Amplitudes of store-operated currents as a function of time after 1µM
thapsigargin application to Neuro-2a cells expressing Htt138Q-1exon (black
squares) or Htt15Q-1exon (gray circles) and to control Neuro-2a cells (light
gray triangles). The amplitude of the currents for all groups of cells was
measured at a potential of –80mV. Data from representative experiments are
shown. (B) Average I/V curves for currents evoked by passive Ca2+ calcium
store depletion with 1µM thapsigargin in Neuro-2a cells expressing
Htt138Q-1exon (black line) or Htt15Q-1exon (gray line) and in control
Neuro-2a cells (light gray line). Measurements were made when the currents
reached a maximum.
NMDG (N-methyl-D-glucamine), EVP4593 (4-N-[2-(4-
phenoxyphenyl)ethyl]quinazoline-4,6-diamine), Tris, HEPES,
EGTA, EDTA, Triton X-100, and Nifedipine.
RESULTS
SOCE is Pathologically Enhanced in
Neuro-2a Cells Expressing Mutant
Huntingtin Exon 1
It has been shown that the interaction between mutant
huntingtin and IP3 receptor (IP3R) leads to an increased affinity
of the latter to IP3,which affects intracellular calcium deposition
(Tang et al., 2003). We have previously found that SOCE in
SK-N-SH human neuroblastoma cells is enhanced due to the
expression of full-length mutant huntingtin (Glushankova et al.,
2010; Wu et al., 2011), whereas, according to Tang et al. (2003),
the expression of exon 1 of mutated huntingtin (Htt138Q-1exon)
alone is sufficient for enhancing the affinity of IP3R to IP3. Hence,
the question arose as to whether the observed abnormalities of
SOCE are associated specifically with the expression of mutant
huntingtin exon 1 (Htt138Q-1exon).
To find the answer, we used Neuro-2a cells infected with
Lenti-Htt138Q-1exon. Cells infected with Lenti-Htt15Q-1exon
(normal huntingtin exon 1) and intact (noninfected) Neuro-2a
cells served as controls.
To provide the evidence that Neuro-2a cells are adequate
for HD modeling we measured a toxic effect of the mutant
huntingtin using a propidium iodide approach. The results
indicated that levels of dead cells in control Neuro-2a, Neuro-
2a Htt15Q-1exon and Neuro-2a Htt138Q-1exon (48 h after
lentiviral infection) were 32 ± 2%, 29 ± 3% and 45 ± 5%
respectively.
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FIGURE 2 | Store-operated calcium currents in Neuro-2a Htt138Q-1exon cells upon suppression of STIM1. (A) Amplitudes of store-operated currents as a
function of time after 1µM thapsigargin application to Neuro-2a cells expressing Htt138Q-1exon and control shRNA (black squares) or Htt138Q-1exon and shRNA
against STIM1 (gray circles), and to control Neuro-2a cells (light gray triangles). The amplitude of the currents for all groups of cells was measured at a potential
of −80mV. Data from representative experiments are shown. (B) Average I/V curves for currents evoked by passive Ca2+ store depletion with 1µM thapsigargin in
Neuro-2a cells expressing Htt138Q-1exon and control shRNA (black line) or Htt138Q-1exon and shRNA against STIM1 (gray line) and in control Neuro-2a cells (light
gray line). Measurements were made when the currents reached a maximum. Each curve is based on the number of experiments indicated in (C). Suppression of
STIM1 was confirmed by Western blotting. (C) Average amplitudes of store-operated currents in Neuro-2a cells expressing Htt138Q-1exon and control shRNA (black
bar) or Htt138Q-1exon and shRNA against STIM1 (gray bar) and in control Neuro-2a cells (light gray bar). Measurements in all groups of cells were made at a
potential of −80mV and plotted as means ± SEM (*p < 0.05). Figures above the bars show the number of experiments.
To activate SOC channels, the cells were treated with 1µM
Thapsigargin (Tg), which causes passive depletion of intracellular
calcium stores. Therefore, we considered that it was the currents
through the SOC channels that were recorded during the
experiment. Whole cell recordings showed that the amplitudes of
these currents after complete SOC channel activation in Neuro-
2a Htt138Q-1exon, Neuro-2a Htt15Q-1exon, and in control
Neuro-2a cells were 2.78 ± 0.46 pA/pF, 1.01 ± 0.21 pA/pF, and
1.17± 0.22 pA/pF, respectively, at –80mV (Figures 1A,B).
Thus, using the Neuro-2a cells we have found that the
expression of the Htt138Q-1exon leads to an abnormal increase
in SOCE, as does the expression of the full-length mutant
huntingtin in SK-N-SH cells (Glushankova et al., 2010; Wu et al.,
2011). Furthermore in our experiments the increase in SOCE in
Neuro-2a Htt138Q-1exon well correlates with enhanced level of
cell death.
Calcium Sensor STIM1 is Required for SOC
Channel Activation in Neuro-2a
Htt138Q-1exon Cells
The known ER-resident single-pass proteins STIM1 and STIM2
are homologous molecules that function as Ca2+ sensors and
activators of SOCE (Dziadek and Johnstone, 2007; Gruszczynska-
Biegala et al., 2011). The Ca2+-binding domains of STIMproteins
are identical, except for three residues, but STIM1 is twice as
sensitive to Ca2+ changes in the ER lumen, compared to STIM2
(Brandman et al., 2007), and is therefore regarded as a stronger
activator of SOCE.
To analyze the role of STIM1 in activation of SOCE in Neuro-
2a Htt138Q-1exon cells, we suppressed its expression by RNAi
knockdown. As a control we used the untargeted shRNA SCH002
(ctrl shRNA). Electrophysiological recordings indicated a twofold
reduction of the SOCE level in knockdown cells: the amplitude
of Tg-induced Ca2+ currents decreased to 1.28 ± 0.17 pA/pF,
compared to 2.47 ± 0.51 pA/pF in control cells with the normal
expression of STIM1 (Figures 2A–C).
These results suggest that STIM1 is responsible for the
abnormal activity of SOC channels in Neuro-2a 138Q-1exon
cells.
Suppression of Either TRPC1 or Orai1
Reduces the SOCE Level in Neuro-2a
Htt138Q-1exon Cells
To elucidate the role of TRPC1 in the maintenance of SOCE
in Neuro-2a Htt138Q-1exon cells, experiments on its shRNA
knockdown were performed. Recordings of SOCE levels in
Neuro-2a Htt138Q-1exon cells showed that Tg-induced Ca2+
currents in TRPC1 knockdown cells decreased from 2.33 ± 0.65
to 0.68 ± 0.10 pA/pF (Figures 3A,C,F). As shown previously,
TRPC1 can operate as a sarcoplasmic reticulum calcium leak
channel in skeletal muscle (Berbey et al., 2009). Therefore, the
reduction of SOCE in Neuro-2a Htt138Q-1exon TRPC1(–) cells
could be explained in two ways. On the one hand, TRPC1
knockdown could affect SOCE through TRPC1-containing
channels in the plasma membrane. On the other hand, the
decrease in Ca2+ entry through the SOC channels could be
evoked by deregulation of TRPC1-mediated calcium leak from
the ER lumen.
To gain a deeper insight into the role of TRPC1 in SOCE
regulation, Fura-2 Ca2+ imaging in Neuro-2a cells was used. The
results showed that TRPC1 knockdown did not alter parameters
of Tg-induced intracellular Ca2+ store depletion but reduced
store-mediated Ca2+ influx by 31% (Figure 4A). On the other
hand, the overexpression of TRPC1 resulted in a 84% increase in
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FIGURE 3 | Store-operated calcium currents in Neuro-2a
Htt138Q-1exon cells upon suppression of TRPC1 and Orai1.
(A) Amplitudes of store-operated currents as a function of time after 1µM
thapsigargin application to Neuro-2a cells expressing Htt138Q-1exon and
control shRNA (black squares) or Htt138Q-1exon and shRNA against TRPC1
(gray circles) and to control Neuro-2a cells (light gray triangles). Here and in
(B), the amplitude of the currents for all groups of cells was measured at a
potential of −80mV, data from representative experiments are shown.
(B) Amplitudes of store-operated currents as a function of time after 1µM
thapsigargin application to Neuro-2a cells expressing Htt138Q-1exon and
control shRNA (black squares) or Htt138Q-1exon and shRNA against Orai1
(gray circles) and to control Neuro-2a cells (light gray triangles). (C) Average I/V
curves for currents evoked by passive depletion of calcium stores with 1µM
thapsigargin in Neuro-2a cells expressing Htt138Q-1exon and control shRNA
(black line) or Htt138Q-1exon and shRNA against TRPC1 (gray line) and in
control Neuro-2a cells (light gray line). Here and in (D,E), measurements were
made when the currents reached a maximum; each curve is based on the
number of experiments indicated in (F). Suppression of TRPC1 was confirmed
by Western blotting. (D) Average I/V curves for currents evoked by passive
depletion of calcium stores with 1µM thapsigargin in Neuro-2a cells
expressing Htt138Q-1exon and control shRNA (black line) or Htt138Q-1exon
and shRNA against Orai1 (gray line) and in control Neuro-2a cells (light gray
line). Suppression of Orai1 was confirmed by Western blotting. (E) Average I/V
curves of currents evoked by passive depletion of calcium stores with 1µM
thapsigargin in Neuro-2a cells expressing Htt138Q-1exon and control shRNA
(black line) or Htt138Q-1exon and shRNAs against both TRPC1 and Orai1
(gray line) and in control Neuro-2a cells (light gray line). (F) Average amplitudes
of store-operated currents in Neuro-2a cells expressing Htt138Q-1exon and
control shRNA (black bar), Htt138Q-1exon and shRNA against TRPC1
(Continued)
FIGURE 3 | Continued
(vertically shaded bar), Htt138Q-1exon and shRNA against Orai1 (horizontally
shaded bar), or Htt138Q-1exon and shRNAs against both TRPC1 and Orai1
(diagonally shaded bar) and in control Neuro-2a cells (light gray bar).
Measurements in all groups of cells were made at a potential of −80mV and
plotted as means ± SEM (*p < 0.05). Figures above the bars show the
number of experiments.
FIGURE 4 | Results of Ca2+-imaging in Neuro-2a cell with suppression
or overexpression of TRPC1. (A) Responses of cytosolic Ca2+ level to
1µM thapsigargin application in control Neuro-2a cells (black line) and
Neuro-2a cells expressing shRNA against TRPC1 (light gray line) plotted as a
portion of that in control cells. (B) Responses of cytosolic Ca2+ level to 1µM
thapsigargin application in control Neuro-2a cells (black line) and Neuro-2a
cells expressing the construct for TPRC1 overexpression (light gray line)
plotted as a portion of that in control cells.
SOCE but had no effect on parameters of Tg-induced depletion
of intracellular Ca2+ stores (Figure 4B). This is evidence that
TRPC1 channels maintain calcium currents through the plasma
membrane but not through the membranes of ER.
It should be noted that TRPC1 knockdown in Neuro-2a
Htt138Q-1exon cells caused not only reduction in the amplitude
of Tg-induced SOC currents but also changes in the shape of
corresponding I/V curves (Figure 3C). These curves in Neuro-
2a Htt138Q-1exon cells with normal TRPC1 expression were
linear, as in control Neuro-2a cells, but their shape after TRPC1
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suppression was indicative of inward rectification of Tg-induced
currents.
It is well known that Orai1 forms highly selective CRAC
channels that are characterized by inward rectification. Taking
into account the shape of the I/V curve in Neuro-2a Htt138Q-
1exon cells with TRPC1 knockdown (Figure 3C), we supposed
that Orai1 could also maintain SOCE in the Neuro-2a cell
model of HD. Therefore, experiments on Orai1 knockdown in
Neuro-2a Htt138Q-1exon cells were performed, and the results
confirmed approximately threefold reduction of SOCE after this
treatment: from 2.62 ± 0.67 to 0.76 ± 0.17 pA/pF at −80mV
(Figures 3B,D,F).
Thus, knockdown of either TRPC1 or Orai1 proved to result
in a dramatic decrease (by 70–75%) of SOCE in Neuro-2a
Htt138Q-1exon cells (Figures 3A–D,F), suggesting that TRPC1
and Orai1 cooperate in maintaining SOCE in these cells.
To test this hypothesis, we studied Tg-induced currents in
Neuro-2a Htt138Q-1exon cells with knockdown of both TRPC1
and Orai1. The electrophysiological recordings indicated that
SOCE in such cells was reduced from 2.54 ± 0.40 to 0.65 ±
0.16 pA/pF (Figures 3E,F); i.e., this double knockdown did not
attenuate SOC currents to a greater extent than did that of TRPC1
or Orai1 alone. Such a result indicates that the effect of TRPC1
and Orai1 on SOCE is not additive but the combined action
of these proteins is required for its maintenance in Neuro-2a
Htt138Q-1exon cells.
MSNs Show a Pathological SOCE
Phenotype Upon the Expression of Mutant
Huntingtin Exon 1
HD leads to extensive degeneration of neurons, predominantly
in the striatum, with MSNs being affected to the greatest extent.
Therefore, the investigation ofmutant huntingtin effect onMSN’s
phenotype may be regarded highly relevant for HD pathology
studies.
In our experiments, we used MSNs infected with Lenti-
Htt138Q-1exon, while MSNs with the normal Htt15Q-1exon and
noninfected MSNs served as controls. Whole-cell measurements
showed that amplitudes of Tg-induced currents in the respective
MSN groups were 1.93 ± 0.31 vs. 0.97 ± 0.19 and 0.75 ±
0.25 pA/pF (Figures 5A,B), confirming pathological SOCE
enhancement in the MSNs Htt138Q-1exon.
It could be supposed that similar enhancing effects on SOCE
observed in different cells, expressing Htt138Q-1exon may be
accounted for by the same molecular players. Therefore, we
investigated the roles of STIM1, TRPC1, and Orai1 in the
activation and maintenance of SOCE in MSNs Htt138Q-1exon.
The results showed that RNAi knockdown of STIM1 reduced
SOCE in Htt138Q-1exon MSNs from 1.84 ± 0.40 to 0.64 ± 0.06
pA/pF (Figures 5C,F). Thus, we confirmed that STIM1 drives
the activity of SOC channels in MSNs Htt138Q-1exon as well
as in Neuro-2a Htt138Q-1exon cells. Moreover, suppression of
TRPC1 and Orai1 also attenuated Tg-induced SOC currents in
Htt138Q-1exon MSNs from 2.22 ± 0.32 to 0.94 ± 0.21 pA/pF
(Figures 5D,F) and from 2.10 ± 0.21 to 0.99 ± 0.15 pA/pF
(Figures 5E,F), respectively.
FIGURE 5 | Store-operated calcium currents in MSN Htt138Q-1exon
cells upon suppression of STIM1, TRPC1, and Orai1. (A) Amplitudes of
store-operated currents as a function of time after application of 1µM
thapsigargin to MSNs expressing the Htt138Q-1exon (black triangles), the
Htt15Q-1exon (gray circles), control MSNs (light gray squares). The amplitude
of the currents for all groups of cells was measured at a potential of −80mV.
Data from representative experiments are shown. (B) Average I/V curves for
currents evoked by passive depletion of calcium stores with 1µM thapsigargin
in MSNs expressing Htt138Q-1exon (black line, 7 experiments) or
Htt15Q-1exon (gray line, 6 experiments), and in control MSNs (light gray line,
15 experiments). Here and in (C–E), measurements were made when the
currents reached a maximum. (C) Average I/V curves for currents evoked by
passive depletion of calcium stores with 1µM thapsigargin in MSNs
expressing Htt138Q-1exon and control shRNA (black line) or Htt138Q-1exon
and shRNA against STIM1 (gray line) and in control MSNs (light gray line).
Suppression of STIM1 was confirmed by Western blotting. (D) Average I/V
curves for currents evoked by passive depletion of calcium stores with 1µM
thapsigargin in MSNs expressing Htt138Q-1exon and control shRNA (black
line) or Htt138Q-1exon and shRNA against TRPC1 (gray line) and in control
MSNs (light gray line). Suppression of TRPC1 was confirmed by Western
blotting. (E) Average I/V curves for currents evoked by passive depletion of
calcium stores with 1µM thapsigargin in MSNs expressing Htt138Q-1exon
and control shRNA (black line) or Htt138Q-1exon and shRNA against Orai1
(gray line) and in control MSNs (light gray line). Suppression of Orai1 was
confirmed by Western blotting. (F) Average amplitudes of store-operated
currents in MSNs expressing Htt138Q-1exon and control shRNA (black bar),
Htt138Q-1exon and shRNA against STIM1 (vertically shaded bar),
Htt138Q-1exon and shRNA against TRPC1 (horizontally shaded bar), or
Htt138Q-1exon and shRNA against Orai1 (diagonally shaded bar) and in
control MSNs (light gray bar). Measurements in all groups of cells were made
at a potential of −80mV and plotted as means ± SEM (*p < 0.05). Figures
above the bars show the number of experiments.
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FIGURE 6 | Store-operated calcium currents in Htt138Q-1exon MSNs are reduced upon treatment with EVP4593 compound. (A) Amplitudes of
store-operated currents as a function of time after 1µM Thapsigargin application to MSNs expressing Htt138Q-1exon and treated with DMSO (black squares) or with
0.3µM EVP4593 (gray circles). The amplitude of the currents for both groups of cells was measured at a potential of −80mV. Data from representative experiments
are shown. (B) Average I/V curves for currents evoked by passive depletion of calcium stores with 1µM thapsigargin in MSNs expressing the Htt138Q-1exon and
treated with DMSO (black line) or with 0.3µM EVP4593 (gray line) and in control MSNs (light gray line). Measurements were made when the currents reached a
maximum. Each curve is based on the number of experiments indicated in (C). (C) Average amplitudes of store-operated currents in MSNs expressing
Htt138Q-1exon and treated with DMSO (black bar) or with 0.3µM EVP4593 (gray bar) and in control MSNs (light gray bar). Measurements in all groups of cells were
made at a potential of −80mV and plotted as means ± SEM (*p < 0.05). Figures above the bars show the number of experiments.
This is evidence that TRPC1 and Orai1 play an essential role
in maintaining SOCE in MSNs, expressing mutant huntingtin
exon 1.
Application of EVP4593 Decreases SOCE
in MSNs Htt138Q-1exon
We have previously demonstrated the ability of quinazoline-
derived compound EVP4593 to improve the motor phenotype
of flies in a Drosophila HD model and to rescue the primary
culture of MSNs isolated from YAC128Q mice from glutamate-
induced apoptosis (Wu et al., 2011). Furthermore, the results of
our experiments on the SK-N-SH-based HDmodel show that the
potential therapeutic effect of EVP4593 may be connected with
inhibition of pathologically enhanced SOCE.
Here, we tested EVP4593 for the ability to reduce the currents
via the SOC channels in primary culture of MSNs infected with
Htt138Q-1exon. Whole-cell recordings of Tg-induced calcium
entry in Htt138Q-1exon MSNs indicated that treatment with
0.3µM EVP4593 indeed reduced the SOC currents from 1.73 ±
0.22 to 0.73 ± 0.23 pA/pF, returning them to the normal level
(Figures 6A–C).
DISCUSSION
It has been suggested that impaired calcium signaling plays
an essential role in HD pathogenesis. The mutated huntingtin
can disturb cell calcium homeostasis in many ways, including
changes in calcium buffering capacity (Gerfen et al., 1985; Luthi-
Carter et al., 2000), improper regulation of calcium channels
(Swayne et al., 2005; Romero et al., 2008), increased vulnerability
to excitotoxicity (Graham et al., 2009; Milnerwood et al.,
2010), and changes in the mitochondrial membrane permeability
(Panov et al., 2002; Reddy and Shirendeb, 2012).
Most of known effects of mutated huntingtin on calcium
signaling involve an increase in the intracellular calcium level,
which can lead to calcium overload of mitochondria, activation
of caspases, and eventual cell death. Therefore, a number of
proteins involved in the regulation of calcium homeostasis can
be considered as potential targets for HD therapy.
In our previous studies, an abnormal calcium entry through
the SOC channels was observed in the human neuroblastoma
(SK-N-SH) cell model of HD (Glushankova et al., 2010; Wu
et al., 2011), and Fura-2 calcium imaging experiments provided
evidence for enhanced SOCE in primary culture of striatal
neurons from YAC128 mice (Wu et al., 2011).
The results presented above show that the expression of the
first exon of mutant huntingtin alone is sufficient for MSNs and
Neuro-2a cells to acquire an abnormal SOCE phenotype. They
are in good agreement with the data by Tang et al. (2003) that the
affinity of IP3R to IP3 increases when only this exon of mutant
huntingtin is expressed.
In contrast to our data on the enhancement of SOCE in the
Neuro-2a, SK-N-SH, MSNs, and YAC128 mice models of HD,
the research group of Dr. Kuznicki revealed a decrease of SOCE
in nonexcitable PC12 cells used as an HD model (Czeredys et al.,
2013). These authors also found that a number of proteins that
have been shown to be upregulated in striatal neurons isolated
from YAC128 mice—such as huntingtin associated protein 1
(Hap1), calretinin (Calb2) and anterior pharynx defective 1
homolog isoform b (Aph1b)—remained at the same expression
level in HD PC12 cells as in control cells. A probable explanation
is that the decrease of SOCE in this case is a compensatory
effect aimed at reducing cell death. It also appears that
nonexcitable PC12 cells, compared to neurons or neuroblastoma
cells, are less adequate for modeling neurodegenerative
diseases.
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The results of this study show that the increase in SOCE
caused by the expression of exon 1 of the mutated huntingtin
gene in Neuro-2a andMSNs is maintained by TRPC1-containing
channels, as was previously observed in cells expressing mutant
huntingtin (Wu et al., 2011). The involvement of TRPC1 in
pathological calcium influx in the cells is also confirmed by
recent data that TRPC1 knockdown or blocking of TRPC
channels using 2-aminoethoxydiphenyl borate (2-APB) protects
murine hippocampal cell line HT22 against glutamate toxicity
(Narayanan et al., 2014). Taken together, these data suggest that
TRPC1 may represent a potential drug target for treatment of
glutamate toxicity and neurodegeneration.
According to previous data, TRPC1 operates as a sarcoplasmic
reticulum calcium leak channel in skeletal muscle (Berbey et al.,
2009). In contrast, our results suggest that TRPC1 acts as a
subunit of SOC channels in the plasma membrane but not as a
leak channel in the ER membrane, at least in Neuro-2a cells.
We have also shown here that calcium sensor STIM1 is
required for maintaining SOCE in Neuro-2a Htt138Q-1exon and
MSNs Htt138Q-1exon cells. It is known that STIM1 activates
CRAC channels composed by Orai1 subunits in many cell
types (Li et al., 2007; Luik et al., 2008). One of the most
controversial targets for STIM1 is the family of TRPC channels.
STIM-dependent activation of TRPC channels is reported in
a number of publications (Huang et al., 2006; Worley et al.,
2007), but contrary evidence is provided in studies by other
research groups (Yuan et al., 2007; Lee et al., 2010). It has
also been considered that the effect of store depletion on TRPC
channel activation may be indirect. As shown by the group
of Dr. Ambudkar, the Orai1-mediated current causes TRPC1
insertion into the plasma membrane, with subsequent activation
of TRPC1-mediated channels (Cheng et al., 2011).
Our data indicate that the knockdown of either TRPC1 or
Orai1 in Neuro-2a Htt138Q-1exon cells leads to a dramatic
decrease in SOCE (about 70–75%) (Figure 3), with the
suppression of both TRPC1 and Orai1 causing no additional
attenuation of SOC currents (Figures 3E,F). These data
indirectly confirm the results obtained by the group of Dr.
Ambudkar regarding crutial role of Orai1-mediated current in
TRPC1 insertion into the plasma membrane (Cheng et al., 2011).
It is possible to assume that dramatic reduction of SOCE in
Neuro-2a Htt138Q-1exon after Orai1 knockdown is not caused
by the decrease of current via Orai1-containing channels only.
In light of Dr. Ambudkar’s data we may suppose that Orai1
knockdown could lead to reduction of TRPC1-mediated part
of SOC current caused by the deficiency of TRPC1 in plasma
membrane. It can also assume that SOCE in Neuro-2a Htt138Q-
1exon cells is maintained by channels that include both TRPC1
and Orai1 as pore-forming or regulatory subunits. Previously it
has been already hypothesized that native SOCE is mediated by
TRPCs channels with Orai acting as a regulatory subunit (Liao
et al., 2007) or that Orai1 and TRPC1 may form heteromeric
channels with properties distinct from that mediated by Orai1
or TRPC1 alone (Liao et al., 2008). However, neither of these
proposals has been further supported by studies or conclusive
data. Thus, the question regarding TRPC1-Orai1 cooperation
is still unclear and requires further investigation. Altogether
we may conclude that both TRPC1 and Orai1 are required
for SOCE maintenance in Neuro-2a Htt138Q-1exon cells and
very likely TRPC1-mediated SOCE is not independent from
Orai1.
The results of MSNs treatment with EVP4593 confirm the
Ca2+ imaging data obtained by Dr. Bezprozvanny’s group in
experiments with MSNs isolated from YAC128 mice and well
agree with the data on a neuroprotective effect of EVP4593 in
glutamate toxicity assays (Wu et al., 2011).
In summary, the data presented above show that SOCE and
proteins playing a key role in its activation and maintenance may
be the promising targets for neurodegeneration drug discovery.
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